Physician Lead of HF Clinic
CHFS and CSE
Queen's University
Dr. Aws Almufleh received his medical degree with First Class Honors from King Saud University, Riyadh, Saudi Arabia in 2012. He then completed a Master of Public Health (MPH) at the University of Miami focusing on epidemiology and clinical research. He did internal medicine residency at McGill University where he served as the Chief Medical Resident. Following cardiology fellowship training at the University of Ottawa Heart Institute (2016-2019), Dr. Almufleh completed an advanced heart failure and cardiac transplantation fellowship at the Brigham and Women’s Hospital/Harvard Medical School (2019-2020) and earned the Pierce Fellow Award for Scholarship in Cardiomyopathy in recognition of his clinical and research achievements. Dr. Almufleh also completed an advanced echocardiography fellowship at Vancouver General Hospital/University of British Columbia (2020-2021). Concurrently, completed the Global Clinical Scholars Research Training (GCSRT) program at Harvard Medical School with emphasis on advanced quantitative research methodology and study design.
Dr. Almufleh’s clinical and research interests lie in optimizing outpatient management of patients with heart failure with reduced ejection fraction, particularly in light of the rapid expansion of heart failure pharmacotherapy and the increasing challenges of therapeutic inertia. Besides research pursuit, Dr. Almufleh is the Echocardiography education director for Cardiology and POCUS fellows at Queen's University and is currently participating on several medical education projects aimed at optimizing echocardiography competency training during cardiology fellowship and improving guidelines-directed medical therapy titration skills among cardiology trainees. He co-authored the 2023 CCS/CSE Standards for Physician Training and Maintenance of Competence in Echocardiography published at the Canadian Journal of Cardiology.
In September 2021, Dr. Almufleh joined the Department of Medicine at Queen’s University as an Assistant Professor of Medicine and the Physician Lead of the Heart Function Clinic in addition to his role in the Echocardiography Laboratory.
Disclosure(s): Boehringer Ingelheim: Speaker honoraria (Ongoing); Novartis: Quality improvement project (Terminated, November 16, 2023); Novo Nordisk: Consultant/Advisory Board (Terminated, May 29, 2024); Pfizer: Advisory board (Ongoing), Quality improvement project (Ongoing), Speaker honoraria (Ongoing)
260 - DEMYSTIFYING THE ROLE OF COMMUNITY PARAMEDICS IN AMBULATORY HEART FAILURE MANAGEMENT
Friday, October 25, 2024
4:30 PM – 5:30 PM PT
323 - CHFS SPOTLIGHT: WHAT TO DO WHEN PATIENTS FALL OUTSIDE OF CLINICAL TRIALS' INCLUSION CRITERIA?
Saturday, October 26, 2024
9:45 AM – 10:45 AM PT
331 - CCTN/CHFS RESEARCH COMPETITION
Saturday, October 26, 2024
11:00 AM – 12:00 PM PT